MAC
MRNA icon

Mason & Associates (California)’s Moderna MRNA Stock Holding History

Mason & Associates (California)’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,929
Closed -$465K – 88
2022
Q3 		$465K Buy
3,929
+3
+0.1% +$455 0.16% 46
2022
Q2 		$561K Sell
3,926
-334
-8% -$47.7K 0.2% 45
2022
Q1 		$734K Sell
4,260
-502
-11% -$84.5K 0.22% 47
2021
Q4 		$1.21M Buy
+4,762
New +$1.39M 0.37% 35

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mason & Associates (California)'s MRNA Position: Q4 2022 in Review

Mason & Associates (California) sold out of Moderna (MRNA) in Q4 2022, closing a stake of 3,929 shares — an estimated $465K sold.

Mason & Associates (California) first reported a position in MRNA in Q4 2021 and held it in 4 quarters. The position peaked at $1.21M in Q4 2021. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • Mason & Associates (California) reported no remaining Moderna position as of Q4 2022 after selling out during the quarter.
  • Mason & Associates (California) sold 3,929 Moderna shares in Q4 2022, an estimated $465K.
  • Mason & Associates (California) first reported a position in Moderna in Q4 2021 and held it in 4 quarters.
  • Mason & Associates (California)'s Moderna position peaked at $1.21M in Q4 2021.
  • 1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on Mason & Associates (California)'s 13F filing for Q4 2022, filed 13 Jan 2023.